AxoGen Common Stock Net 2010-2025 | AXGN
AxoGen common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
| AxoGen Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| AxoGen Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-06-30 | $0 |
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.647B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $171.715B | 20.77 |
| Intuitive Surgical (ISRG) | United States | $168.416B | 69.81 |
| IDEXX Laboratories (IDXX) | United States | $52.008B | 54.13 |
| Edwards Lifesciences (EW) | United States | $45.753B | 30.32 |
| Alcon (ALC) | Switzerland | $42.148B | 28.48 |
| IQVIA Holdings (IQV) | United States | $30.422B | 17.19 |
| DexCom (DXCM) | United States | $29.961B | 44.94 |
| Mettler-Toledo (MTD) | United States | $25.480B | 30.24 |
| STERIS (STE) | Ireland | $23.239B | 24.76 |
| Waters (WAT) | United States | $16.548B | 22.73 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.365B | 0.00 |
| Hologic (HOLX) | United States | $15.109B | 16.37 |
| Penumbra (PEN) | United States | $9.389B | 68.59 |
| Sysmex ADR (SSMXY) | Japan | $8.643B | 27.46 |
| Masimo (MASI) | United States | $7.872B | 26.49 |
| Globus Medical (GMED) | United States | $7.320B | 16.84 |
| Teleflex (TFX) | United States | $5.104B | 8.24 |
| Glaukos (GKOS) | United States | $5.047B | 0.00 |
| TransMedics (TMDX) | United States | $3.956B | 60.13 |
| Integer Holdings (ITGR) | United States | $3.704B | 18.48 |
| LivaNova (LIVN) | United Kingdom | $2.649B | 15.16 |
| Alphatec Holdings (ATEC) | United States | $2.205B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.190B | 0.00 |
| Veracyte (VCYT) | United States | $2.168B | 30.09 |
| Nihon Kohden (NHNKY) | Japan | $1.962B | 23.42 |
| Elekta AB (EKTAY) | Sweden | $1.862B | 16.74 |
| Artivion (AORT) | United States | $1.396B | 77.86 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.64 |
| OPKO Health (OPK) | United States | $0.976B | 0.00 |
| IRadimed (IRMD) | United States | $0.877B | 42.57 |
| Tandem Diabetes Care (TNDM) | United States | $0.778B | 0.00 |
| SiBone (SIBN) | United States | $0.704B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.656B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.556B | 4.46 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.498B | 8.80 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.498B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.378B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.357B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.356B | 84.92 |
| Mesa Laboratories (MLAB) | United States | $0.349B | 8.88 |
| AngioDynamics (ANGO) | United States | $0.347B | 0.00 |
| RxSight (RXST) | United States | $0.317B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.306B | 0.00 |
| NeuroPace (NPCE) | United States | $0.293B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.277B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.277B | 19.14 |
| Neuronetics (STIM) | United States | $0.265B | 0.00 |
| 908 Devices (MASS) | United States | $0.230B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.194B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.184B | 0.00 |
| CVRx (CVRX) | United States | $0.181B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.149B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.130B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.106B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| InspireMD (NSPR) | United States | $0.100B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.091B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.088B | 0.00 |
| Spectral AI (MDAI) | United States | $0.061B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.048B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.60 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |